Bio-Rad Laboratories Inc (BIO)
278.21
-7.07
(-2.48%)
USD |
NYSE |
Apr 24, 16:00
278.08
-0.13
(-0.05%)
Pre-Market: 20:00
Bio-Rad Laboratories Research and Development Expense (Quarterly): 63.90M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 63.90M |
| September 30, 2023 | 43.54M |
| June 30, 2023 | 65.04M |
| March 31, 2023 | 74.95M |
| December 31, 2022 | 66.20M |
| September 30, 2022 | 66.81M |
| June 30, 2022 | 64.35M |
| March 31, 2022 | 59.54M |
| December 31, 2021 | 58.85M |
| September 30, 2021 | 64.48M |
| June 30, 2021 | 63.39M |
| March 31, 2021 | 73.91M |
| December 31, 2020 | 56.93M |
| September 30, 2020 | 59.55M |
| June 30, 2020 | 51.98M |
| March 31, 2020 | 49.30M |
| December 31, 2019 | 57.07M |
| September 30, 2019 | 47.94M |
| June 30, 2019 | 50.12M |
| March 31, 2019 | 47.58M |
| December 31, 2018 | 53.07M |
| September 30, 2018 | 49.24M |
| June 30, 2018 | 47.45M |
| March 31, 2018 | 49.43M |
| December 31, 2017 | 76.04M |
| Date | Value |
|---|---|
| September 30, 2017 | 62.08M |
| June 30, 2017 | 62.59M |
| March 31, 2017 | 49.45M |
| December 31, 2016 | 57.39M |
| September 30, 2016 | 49.92M |
| June 30, 2016 | 49.81M |
| March 31, 2016 | 48.59M |
| December 31, 2015 | 55.89M |
| September 30, 2015 | 43.34M |
| June 30, 2015 | 46.55M |
| March 31, 2015 | 47.20M |
| December 31, 2014 | 59.29M |
| September 30, 2014 | 52.79M |
| June 30, 2014 | 55.72M |
| March 31, 2014 | 52.54M |
| December 31, 2013 | 55.85M |
| September 30, 2013 | 52.92M |
| June 30, 2013 | 51.84M |
| March 31, 2013 | 50.34M |
| December 31, 2012 | 58.57M |
| September 30, 2012 | 47.80M |
| June 30, 2012 | 52.34M |
| March 31, 2012 | 52.92M |
| December 31, 2011 | 41.28M |
| September 30, 2011 | 45.39M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
43.54M
Minimum
Sep 2023
74.95M
Maximum
Mar 2023
59.89M
Average
59.55M
Median
Sep 2020
Research and Development Expense (Quarterly) Benchmarks
| Agilent Technologies Inc | 128.00M |
| Bruker Corp | 83.50M |
| Azenta Inc | 8.493M |
| Harvard Bioscience Inc | 3.15M |
| Bionano Genomics Inc | 11.70M |